PROCTER & GAMBLE Co PG
Last close
146.44
2026-09-04
Market cap
$340.39B
2026-06-30 share count
52-week range
137.62 - 167.25
Valuation FY2026 figures against the last close
P/S3.9x
P/E22.1x
P/FCF22.5x
EV/EBITDA15.7x
Dividend yield3.0%
Diluted EPS6.62
Annual financial statements
Income statement
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $87.03B | $84.28B | $84.04B | $82.01B | $80.19B | $76.12B | $70.95B | $67.68B | $66.83B | $65.06B |
| Cost of revenue | $43.36B | $41.16B | $40.85B | $42.76B | $42.16B | $37.11B | $35.25B | $34.77B | $34.43B | $32.64B |
| Gross profit | $43.67B | $43.12B | $43.19B | $39.25B | $38.03B | $39.01B | $35.70B | $32.92B | $32.40B | $32.42B |
| R&D | $2.10B | $2.10B | $2.00B | $2.00B | $2.00B | $1.90B | $1.80B | $1.90B | $1.90B | $1.90B |
| SG&A | $23.92B | $22.67B | $23.30B | $21.11B | $20.22B | $21.02B | $19.99B | $19.08B | $19.04B | $18.65B |
| Operating income | $19.75B | $20.45B | $18.55B | $18.13B | $17.81B | $17.99B | $15.71B | $5.49B | $13.36B | $13.77B |
| Interest expense | $877.0M | $907.0M | $925.0M | $756.0M | $439.0M | $502.0M | $465.0M | $509.0M | $506.0M | $465.0M |
| Pre-tax income | $20.38B | $20.17B | $18.76B | $18.35B | $18.00B | $17.57B | $15.76B | $6.00B | $13.21B | $18.39B |
| Income tax | $4.23B | $4.10B | $3.79B | $3.62B | $3.20B | $3.26B | $2.73B | $2.10B | $3.46B | $3.06B |
| Net income | $16.10B | $16.10B | $15.00B | $14.70B | $14.80B | $14.31B | $13.03B | $3.90B | $9.75B | $15.33B |
| EPS, basic | 6.75 | 6.67 | 6.18 | 6.07 | 6.00 | 5.69 | 5.13 | 1.45 | 3.75 | 5.80 |
| EPS, diluted | 6.62 | 6.51 | 6.02 | 5.90 | 5.81 | 5.50 | 4.96 | 1.43 | 3.67 | 5.59 |
| Shares, diluted (wtd. avg.) | $2.42B | $2.45B | $2.47B | $2.48B | $2.54B | $2.60B | $2.63B | $2.54B | $2.66B | $2.74B |
Balance sheet
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $9.94B | $9.56B | $9.48B | $8.25B | $7.21B | $10.29B | $16.18B | $4.24B | $2.57B | $5.57B |
| Receivables | $6.06B | $6.18B | $6.12B | $5.47B | $5.14B | $4.72B | $4.18B | $4.95B | $4.69B | $4.59B |
| Inventory | $8.17B | $7.55B | $7.02B | $7.07B | $6.92B | $5.98B | $5.50B | $5.02B | $4.74B | $4.62B |
| Total current assets | $26.21B | $25.39B | $24.71B | $22.65B | $21.65B | $23.09B | $27.99B | $22.47B | $23.32B | $26.49B |
| Property, plant and equipment | $25.36B | $23.90B | $22.15B | $21.91B | $21.20B | $21.69B | $20.69B | $21.27B | $20.60B | $19.89B |
| Goodwill | $41.28B | $41.65B | $40.30B | $40.66B | $39.70B | $40.92B | $39.90B | $40.27B | $45.17B | $44.70B |
| Other intangibles | $21.44B | $21.91B | $22.05B | $23.78B | $23.68B | $23.64B | $23.79B | $24.21B | $23.90B | $24.19B |
| Total assets | $126.52B | $125.23B | $122.37B | $120.83B | $117.21B | $119.31B | $120.70B | $115.09B | $118.31B | $120.41B |
| Accounts payable | $16.31B | $15.23B | $15.36B | $14.60B | $14.88B | $13.72B | $12.07B | $11.26B | $10.34B | $9.63B |
| Short-term debt | $6.46B | $5.38B | $3.84B | $3.95B | $3.65B | $3.62B | $2.51B | $3.39B | $1.77B | $1.68B |
| Total current liabilities | $38.69B | $36.06B | $33.63B | $35.76B | $33.08B | $33.13B | $32.98B | $30.01B | $28.24B | $30.21B |
| Long-term debt | $22.84B | $25.00B | $25.27B | $24.38B | $22.85B | $23.10B | $23.54B | $20.39B | $20.86B | $18.04B |
| Total liabilities | $72.21B | $72.95B | $71.81B | $73.76B | $70.35B | $72.65B | $73.82B | $67.52B | $65.43B | $64.63B |
| Retained earnings | $135.85B | $129.97B | $123.81B | $118.17B | $112.43B | $106.37B | $100.24B | $94.92B | $98.64B | $96.12B |
| Total equity | $54.31B | $52.28B | $50.56B | $47.06B | $46.85B | $46.65B | $46.88B | $47.58B | $52.88B | $55.78B |
Cash flow
| Fiscal year | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $19.56B | $17.82B | $19.85B | $16.85B | $16.72B | $18.37B | $17.40B | $15.24B | $14.87B | $12.75B |
| Depreciation and amortisation | $3.16B | $2.85B | $2.90B | $2.71B | $2.81B | $2.73B | $3.01B | $2.82B | $2.83B | $2.82B |
| Stock-based compensation | $524.0M | $476.0M | $562.0M | $545.0M | $528.0M | $540.0M | $558.0M | $515.0M | $395.0M | $351.0M |
| Capital expenditure | $4.41B | $3.77B | $3.32B | $3.06B | $3.16B | $2.79B | $3.07B | $3.35B | $3.72B | $3.38B |
| Investing cash flow | -$4.62B | -$3.82B | -$3.50B | -$3.50B | -$4.42B | -$2.83B | $3.04B | -$3.49B | -$3.51B | -$6.68B |
| Financing cash flow | -$14.46B | -$14.04B | -$14.86B | -$12.15B | -$14.88B | -$21.53B | -$8.37B | -$9.99B | -$14.38B | -$8.57B |
| Dividends paid | $10.23B | $9.87B | $9.31B | $9.00B | $8.77B | $8.26B | $7.79B | $7.50B | $7.31B | $7.24B |
| Buybacks | $5.03B | $6.50B | $5.01B | $7.35B | $10.00B | $11.01B | $7.41B | $5.00B | $7.00B | $5.20B |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-372211.
Others in SIC 2840
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| ECL | ECOLAB INC. | $78.29B | 38.4x | 2.2% |
| CHD | CHURCH & DWIGHT CO INC /DE/ | $23.38B | 32.6x | 1.6% |
| SCL | STEPAN CO | $1.44B | 30.9x | 7.0% |
| UL | UNILEVER PLC | — | — | — |
| WNW | Meiwu Technology Co Ltd | — | — | 4,368.0% |
| BYAH | Park Ha Biological Technology Co., Ltd. | — | — | 6.0% |